BioCorRx (BICX) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | BioCorRx | - | - | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.50% |
| Dec 31, 2025 | 12.23% |
| Jun 30, 2025 | 31.05% |
| Mar 31, 2025 | 22.78% |
| Dec 31, 2024 | -17.73% |
| Sep 30, 2024 | -7.91% |
| Jun 30, 2024 | 9.57% |
| Mar 31, 2024 | 6.91% |
| Dec 31, 2023 | 17.10% |
| Sep 30, 2023 | 14.39% |
| Jun 30, 2023 | 5.44% |
| Mar 31, 2023 | -0.18% |
| Dec 31, 2022 | 5.85% |
| Sep 30, 2022 | 2.91% |
| Jun 30, 2022 | -16.18% |
| Mar 31, 2022 | 52.32% |
| Dec 31, 2021 | 6.63% |
| Sep 30, 2021 | 12.17% |
| Jun 30, 2021 | 0.22% |
| Mar 31, 2021 | -24.55% |
| Dec 31, 2020 | -179.41% |
| Sep 30, 2020 | -2.40% |
| Jun 30, 2020 | 27.83% |
| Mar 31, 2020 | -39.63% |
| Dec 31, 2019 | 33.92% |
| Sep 30, 2019 | -41.10% |
| Jun 30, 2019 | -51.61% |
| Mar 31, 2019 | -35.21% |
| Dec 31, 2018 | -2.74% |
| Sep 30, 2018 | -60.29% |
| Jun 30, 2018 | -76.43% |
| Mar 31, 2018 | -82.25% |
| Dec 31, 2017 | -33.25% |
| Sep 30, 2017 | -55.62% |
| Jun 30, 2017 | 99.88% |
| Mar 31, 2017 | -358.88% |
| Dec 31, 2016 | -43.89% |
| Sep 30, 2016 | -81.85% |
| Jun 30, 2016 | -73.22% |
| Mar 31, 2016 | -29.21% |
| Dec 31, 2015 | 15.32% |
| Sep 30, 2015 | -165.83% |